Zepp Health Corporation Reports First Quarter of 2026 Unaudited Financial Results
MILPITAS, Calif., June 9, 2026 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the first quarter of 2026. First Quarter of 2026 Financial and Operating Highlights: Revenue reached US$51.5 million, representing 33.8% year-over-year growth, in line with our guidance range. Gross margin was 37.7%, an expansion of...
Beauty of Joseon Named ‘Global No.1 K-Beauty Suncare Brand in Online Sales’ by Euromonitor International
SEOUL, South Korea, June 9, 2026 /PRNewswire/ -- Beauty of Joseon has been recognized by global market intelligence company Euromonitor International as the "Global No.1 K-Beauty Suncare Brand in Online Sales," based on 2025 global online retail sales, further solidifying its position as a leading K-beauty suncare brand worldwide. Beauty of Joseon Named 'Global...
Everest Medicines Enters into Exclusive Asia-Pacific Licensing Agreement with Vcare PharmaTech for Sumecigrel
SHANGHAI, June 9, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an exclusive licensing agreement with Jiangsu Vcare PharmaTech Co., Ltd. ("Vcare PharmaTech"), for the development, registration and commercialization of Sumecigrel (formerly known as Vicagrel)...
THERABODY LAUNCHES CRYOTHERM™ PALM, ITS FIRST THERMOREGULATION PERFORMANCE DEVICE, BRINGING SCIENCE-BACKED PALM COOLING TO MANAGE HEAT ON SPORT’S BIGGEST STAGE
Backed by direct scientific research with elite collegiate and youth athletes, CryoTherm Palm's cooling technology made its debut with the England national team supporting training camps, pre-tournament friendlies, and sideline recovery protocols LOS ANGELES, June 8, 2026 /PRNewswire/ -- Therabody®, the global wellness technology leader, today announced the launch of CryoTherm...
Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis
Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottlenecks. Delivers up to 2x increase in resolving power and sensitivity to identify and track low-level impurities for improved regulatory readiness. Industry-first chemical and physical particle optimization delivers reproducible methods for increasingly...
Zylox-Tonbridge Recognized as Most Honored Company in Extel 2026 Asia Executive Team Survey
HANGZHOU, China, June 8, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190; "Zylox-Tonbridge" or the "Company"), a Hong Kong-listed medical technology company focused on neurovascular and peripheral vascular interventional products and solutions, announced that it has been recognized as a Most Honored Company in Extel's 16th Asia (ex-Japan/ANZ) Executive...
Angel Yeast Showcases Yeast-Based Innovations for Animal Nutrition at TUYEM 2026
SHANGHAI, June 8, 2026 /PRNewswire/ -- Angel Yeast (SH600298), one of the world's leading yeast manufacturers, recently presented its latest research and product developments at the 16th International Feed Congress and Exhibition (TUYEM), with its contributions also highlighted in INFOVET magazine. Dr. George Gong, a technical expert at the company, delivered...
2026 ADA | Innovent Presents Multiple Clinical and Preclinical Results of Next-Generation Obesity & Metabolic Pipeline
SAN FRANCISCO and SUZHOU, China, June 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, presented multiple clinical and preclinical results of its innovative metabolic and obesity pipeline at the 2026...
WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards
DUNDALK, Ireland, June 8, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that its Ireland site won the "Overall Excellence in Life Sciences" award, the highest recognition at the 2026 Life Sciences Industry Awards. The company also was named the winner of the "Life Sciences Team of the...
sweelin® Clinical Trial Results Published in Leading Journal, Food Chemistry, Confirming Blood Glucose Safety
This world's first clinical study on sweet proteins, reflects the clinical relevance of Amai Protein's sweelin®. The double-blind, randomized, crossover clinical study confirmed that sweelin® does not affect blood glucose, insulin and GLP-1 levels compared to stevia and dextrose in healthy adults. sweelin® is a next-generation sweet protein that enables significant sugar reduction and replaces conventional sweeteners with...
